AMPK can also be activated by compounds like 5-aminoimidazole-4-carboxamide-1-β-D-ribofuranoside (AICAR) [106], which increases PGC-1α levels, providing protection from AKI and reducing inflammation. The gene discussed is PPARGC1A; the disease is acute kidney injury.